Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia

Schizophrenia Research

Volumn 103, Issue 1-3, 2008, Pages 71-82

  Steffek, Amy E ^a   McCullumsmith, Robert E ^c   Haroutunian, Vahram ^b   Meador Woodruff, James H ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Anterior cingulate cortex; Astrocyte; Glutamate; Haloperidol; Postmortem; Superior temporal gyrus

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDOL; RISPERIDONE; THIORIDAZINE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MENTAL PATIENT; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA; TEMPORAL LOBE; TREATMENT OUTCOME; VISUAL CORTEX; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CEREBRAL CORTEX; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MALE; PREFRONTAL CORTEX; RATS; REFERENCE VALUES; SCHIZOPHRENIA; TEMPORAL LOBE; VISUAL CORTEX;

EID: 47349112101     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.04.032     Document Type: Article

References (76)

1. Allen N., and Barres B. Signaling between glia and neurons: focus on synaptic plasticity. Current Opinion in Neurobiology 15 5 (2005) 542-548
2. Arif M., Chikuma T., Ahmed M., Yoshida S., and Kato T. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions. Neuroscience Research 57 2 (2007) 248-258
3. Arnold S., Franz B., Trojanowski J., Moberg P., and Gur R. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica. 91 (1996) 269-277
4. Assaf M., Rivkin P., Kuzu C., Calhoun V., Kraut M., Groth K., Yassa M., J.H., and Pearlson G. Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia. Biological Psychiatry 59 5 (2006) 452-459
5. Beasley C., Pennington K., Behan A., Wait R., Dunn M., and Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6 11 (2006) 3414-3425
6. Bellocchio E., Reimer R., Fremeau R., and Edwards R. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289 5481 (2000) 957-960
7. Benes F., Davidson J., and Bird E. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Archives of General Psychiatry. 43 (1986) 31-35
8. Boksha I., Tereshkina E., and Burbaeva G.S. Glutamine synthetase and glutamine synthetase-like protein from human brain. Purification and comparative characterization. Journal of Neurochemistry 75 (2000) 2574-2582
9. Bruneau E., McCullumsmith R., Haroutunian V., Davis K., and Meador-Woodruff J. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophrenia Research 75 1 (2005) 27-34
10. Burbaeva G., Boksha I., Turishcheva M., Vorobyeva E., Savushkina O., and Tereshkina E. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27 4 (2003) 675-680
11. Burbaeva G.S., Boksha I., Tereshkina E., Savushkina O., Turishcheva M., Starodubtseva L., Brusov O., and Morozova M. Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia. World Journal of Biological Psychiatry 7 2 (2006) 75-81
12. Chakrabarti R., McCracken J., Chakrabarti D., and Souba W. Detection of a functional promoter/enhancer in an intronless human gene encoding a GS-like enzyme. Gene 153 (1995) 163-169
13. Chandrakala M., Marcus S., Nadiger H., and Sadasivudu B. Acute and long-term effects of chlorpromazine on glutamine synthetase and glutaminase in rat brain. Journal of Neurochemistry 49 1 (1987) 32-34
14. Chen W., and Liem R. Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons. Journal of Cell Biology 127 3 (1994) 813-823
15. Clinton S., and Meador-Woodruff J. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophrenia Research 69 2-3 (2004) 237-253
16. Clinton S., Haroutunian V., Davis K., and Meador-Woodruff J. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. The American Journal of Psychiatry 160 6 (2003) 1100-1109
17. Clinton S., Haroutunian V., and Meador-Woodruff J. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. Journal of Neurochemistry 98 4 (2006) 1114-1125
18. Cornell-Bell A., Finkbeiner S., Cooper M., and Smith S. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 247 (1990) 470-473
19. Corre S.L., Harper C., Lopez P., Ward P., and Catts S. Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia. Neuroreport 11 5 (2000) 983-986
20. Cotter D., Mackay D., Landau S., Kerwin R., and Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry 58 (2001) 545-553
21. Cotter D., Mackay D., Chana G., Beasley C., Landau S., and Everall I. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 12 (2002) 386-394
22. Coyle J. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Review of Psychiatry 3 (1996) 21-36
23. David J., Ghozali F., Fallet-Bianco C., Wattez A., Delaine S., Boniface B., Menza C.D., and Delacourte A. Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neuroscience Letters 235 1-2 (1997) 53-56
24. Dean B., Gray L., and Scarr E. Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia. Australian and New Zealand Journal of Psychiatry 40 3 (2006) 217-224
25. Dracheva S., Elhakem S., McGurk S., Davis K., and Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. Journal of Neuroscience Research 76 4 (2004) 581-592
26. Dracheva S., Davis K., Chin B., Woo D., Schmeidler J., and Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease 21 3 (2006) 531-540
27. Fatemi S., Laurence J., Araghi-Niknam M., Stary J., Schulz S., Lee S., and Gottesman I. Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophrenia Research 69 (2004) 317-323
28. Garrity A., Pearlson G., McKiernan K., Lloyd D., Kiehl K., and Calhoun V. Aberrant "default mode" functional connectivity in schizophrenia. American Journal of Psychiatry 164 3 (2007) 450-457
29. Gluck M., Thomas R., Davis K., and Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. American Journal of Psychiatry 159 7 (2002) 1165-1173
30. Grimwood S., Slater P., Deakin J., and Hutson P. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 10 3 (1999) 461-465
31. Halim N., Weickert C., McClintock B., Weinberger D., and Lipska B. Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29 6 (2004) 1063-1069
32. Hansen L., Armstrong D., and Terry R. An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiology of Aging 8 1 (1987) 1-6
33. Hashimoto A., Yoshikawa M., Niwa A., and Konno R. Mice lacking d-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801. Brain Research 1033 2 (2005) 210-215
34. Heresco-Levy U., Javitt D., Ebstein R., Vass A., Lichtenberg P., Bar G., Catinari S., and Ermilov M. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biological Psychiatry 57 6 (2005) 577-585
35. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annual Review of Neuroscience 17 (1994) 31-108
36. Huerta I., McCullumsmith R., Haroutunian V., Gimenez-Amaya J., and Meador-Woodruff J. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia. Synapse 59 7 (2006) 394-402
37. Humphries C., Mortimer A., Hirsch S., and Belleroche J.d. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7 12 (1996) 2051-2055
38. Ibrahim H., A.H., Healy D., Haroutunian V., Davis K., and Meador-Woodruff J. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. American Journal of Psychiatry 157 11 (2000) 1811-1823
39. Javitt D. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside Journal of Clinical Psychiatry 9 1 (1987) 12-35
40. Johnston-Wilson N.L., Sims C.D., Hofmann J.-P., Anderson L., Shore A.D., Torrey E.F., and Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Molecular Psychiatry 5 2 (2000) 142-149
41. Karson C., Mrak R., Schluterman K., Sturner W., Sheng J., and Griffin W. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Molecular Psychiatry 4 (1999) 39-45
42. Katsel P., Davis K., Gorman J., and Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophrenia Research 77 2-3 (2005) 241-252
43. Kim S., Choi S., Chao W., and Volsky D. Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes. Journal of Neurochemistry 87 6 (2003) 1485-1498
44. Knable M., Torrey E., Webster M., and Bartko J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Research Bulletin 55 5 (2001) 651-659
45. Kohama S., Goss J., Finch C., and McNeill T. Increases of glial fibrillary acidic protein in the aging female mouse brain. Neurobiology of Aging 16 1 (1995) 59-67
46. Kosenko E., Llansola M., Montoliu C., Monfort P., Rodrigo R., Hernandez-Viadel M., Erceg S., Sanchez-Perez A., and Felipo V. Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide. Neurochemistry International 43 4-5 (2003) 493
47. Kristiansen L., Beneyto M., Haroutunian V., and Meador-Woodruff J. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Molecular Psychiatry 11 8 (2006) 737-747
48. Kristiansen L., Huerta I., Beneyto M., and Meador-Woodruff J. NMDA receptors and schizophrenia. Current Opinion in Pharmacology 7 1 (2007) 48-55
49. Lahti A., Koffel B., LaPorte D., and Tamminga C. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13 (1995) 9-19
50. Laruelle M., Kegeles L., and Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Annals of the New York Academy of Sciences 1003 1 (2003) 138-158
51. Ma J., Ye N., Lange N., and Cohen B. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus. Neuroscience 121 4 (2003) 991-998
52. McCall M., Gregg R., Behringer R., Brenner M., Delaney C., Galbreath E., Zhang C., Pearce R., Chiu S., and Messing A. Targeted deletion in astrocyte intermediate filament (GFAP) alters neuronal physiology. Proceedings of the National Academy of Sciences 93 13 (1996) 6361-6366
53. Meador-Woodruff J., Clinton S., Beneyto M., and McCullumsmith R. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Annals of the New York Academy of Sciences 1003 1 (2003) 75-93
54. Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D., and Rodriguez D. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cellular and Molecular Life Sciences 61 3 (2004) 369-385
55. Nichols N., Day J., Laping N., Johnson S., and Finch C. GFAP mRNA increases with age in rat and human brain. Neurobiology of Aging 14 5 (1993) 421-429
56. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., and Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature 369 6483 (1994) 744-747
57. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
58. Perng M., Su M., Wen S., Li R., Gibbon T., Prescott A., Brenner M., and Quinlan R. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into rosenthal fibers by a pathway that involves filament aggregation and the association of αB-crystallin and HSP27. The American Journal of Human Genetics 79 2 (2006) 197-213
59. Perrone-Bizzozero N., Sower A., Bird E., Benowitz L., Ivins K., and Neve R. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proceedings of the National Academy of Sciences 93 (1996) 14182-14187
60. Prabakaran S., Swatton J., Ryan M., Huffaker S., Huang J., Griffin J., Wayland M., Freeman T., Dudbridge F., Lilley K., Karp N., Hester S., Tkachev D., Mimmack M., Yolken R., Webster M., Torrey E., and Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 9 (2004) 684-697
61. Rajkowska G., Miguel-Hidalgo J., Makkos Z., Meltzer H., Overholser J., and Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophrenia Research 57 2-3 (2002) 127-138
62. Rodnight R., Gonçalves C., Wofchuk S., and Leal R. Control of the phosphorylation of the astrocyte marker glial fibrillary acidic protein (GFAP) in the immature rat hippocampus by glutamate and calcium ions: possible key factor in astrocytic plasticity. Brazilian Journal of Medical and Biological Research 30 (1997) 33253-33338
63. Rothman D., Sibson N., Hyder F., Shen J., Behar K., and Shulman R. In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philosophical Transactions of the Royal Society B: Biological Sciences 354 1387 (1999) 1165-1177
64. Schmitt A., Weber S., Jatzko A., Braus D., and Henn F. Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment. Journal of Neural Transmission 111 1 (2004) 91-100
65. Shibuki K., Gomi H., Chen L., Bao S., Kim J., Wakatsuki H., Fujisaki T., Fujimoto K., Katoh A., and Ikeda T. Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron 16 3 (1996) 587-599
66. Smith R., Haroutunian V., Davis K., and Meador-Woodruff J. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. American Journal of Psychiatry 158 9 (2001) 1393-1399
67. Smith R., Haroutunian V., Davis K., and Meador-Woodruff J. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Neuroreport 12 13 (2001) 2885-2887
68. Sonnewald U., Qu H., and Aschner M. Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. Journal of Pharmacology and Experimental Therapeutics 301 1 (2002) 1-6
69. Spurney C., Baca S., Murray A., Jaskiw G., Kleinman J., and Hyde T. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats. Synapse 34 4 (1999) 266-276
70. Stark A., Uylings H., Sanz-Arigita E., and Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. American Journal of Psychiatry 161 (2004) 882-888
71. Sugai S., Kawamura M., Iritani S., Araki K., Makifuchi T., Imai C., Nakamura R., Kakita A., Takahashi H., and Nawa H. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Annals of the New York Academy of Sciences 1025 (2004) 84-91
72. Takamori S., Rhee J., Rosenmund C., and Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407 6801 (2000) 189-194
73. Toro C., Hallak J., Dunham J., and Deakin J. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neuroscience Letters 404 3 (2006) 276-281
74. Watts J., Fowler L., Whitton P., and Pearce B. Release of arginine, glutamate and glutamine in the hippocampus of freely moving rats: involvement of nitric oxide. Brain Research Bulletin 65 6 (2005) 521
75. Weinberger D., Berman K., and Zec R. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Archives of General Psychiatry 43 2 (1986) 114-124
76. Weinstein D., Shelanski M., and Liem R. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. Journal of Cell Biology 112 6 (1991) 1205-1213